Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-28

FDA Approved: EXPAREL — Original Application (Pacira Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves EXPAREL (bupivacaine liposome injectable suspension) from Pacira Pharmaceuticals in its original application, for postoperative analgesia. This mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

ORIG AP for EXPAREL (BUPIVACAINE)